Jon Russell, MD, PhD, ACR Master Retired Faculty, The University of Texas Health Science Center at San Antonio Editor, Journal of Musculoskeletal Pain Emeritus Founding President of the International MYOPAIN Society Medical Director, Fibromyalgia Research and Consulting Current Affiliation, Arthritis and Osteoporosis Center of South Texas San Antonio, TX Peter Barland, MD (CCME Reviewer) Professor Emeritus, Departments of Medicine and Pathology Albert Einstein College of Medicine of Yeshiva University New York, NY We would like to thank Jane Barbosa Ayala, MD, of the Arthritis & Osteoporosis Center of South Texas; San Antonio, TX, for granting us permission to use materials that belong to her as part of this presentation.
A CME-certified interactive newsletter series on management considerations for fibromyalgia in the primary care setting.
Treating fibromyalgia requires an emphasis on minimizing symptoms and improving general health through a multifaceted approach that may include a combination of medication, behavioral therapy, and lifestyle measures. To achieve better health outcomes and quality of life for their patients with fibromyalgia, primary care clinicians should be able to establish an optimal tailored treatment approach for each patient that includes lifestyle and behavioral approaches to care. The goal of this continuing education activity is to expand the ability of primary care and other clinicians to manage fibromyalgia by exploring all of the treatment options available to them. Program Developer/Facilitator
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
This interactive newsletter series is designed to meet the needs of primary care physicians and other providers who care for patients with fibromyalgia.
Upon completion of this educational activity, the participant should be able to:
Compare the clinical efficacy of lifestyle and behavioral therapies shown to be beneficial in the management of fibromyalgia.
Differentiate the indications, safety, and efficacy of pharmacologic agents used for the treatment of fibromyalgia and its symptoms.
Identify when specialty care may be needed for other symptoms associated with fibromyalgia.
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. Albert Einstein College of Medicine and MCM Education. staff have no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product not yet approved for use in the United States.
Dr. Russell discloses that he has served as a consultant for Jazz Pharmaceuticals and Johnson & Johnson, served on the speakers' bureau for Eli Lilly & Co., and received research funding from Pfizer, Inc.
Dr. Barland has no disclosures.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests other than the following:
Steven Jay Feld, or a member of his household, own securities in: Bioheart Inc.; Chelsea Therapeutics, Inc.; and Pharmacopeia, Inc.
Kathleen Hines (MCM Education medical editor) has no disclosures. Credit Statements
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine, Montefiore Medical Center and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 60% or better on the post-test.
This activity will take approximately 30 minutes to complete. Commercial Support Statements
This activity is supported by an educational grant from Pfizer Inc.
There are no fees for participating in or receiving credit for this online educational activity.
This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.
Review the intended audience, learning objectives, and author disclosures.
Study the educational content online.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
To access this activity users will need
• A computer with an Internet connection.
• Internet Explorer 6.x or higher, Firefox 2.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser. Certificate Fee
Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, the Healthcare Professional Pain Network, and MCM Education.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, the Healthcare Professional Pain Network, or Pfizer Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.